Long-acting blood sugar decreasing fusion protein

  • US 10,017,555 B2
  • Filed: 07/02/2014
  • Issued: 07/10/2018
  • Est. Priority Date: 07/04/2013
  • Status: Active Grant
First Claim
Patent Images

1. A fusion protein obtained by fusing the C-terminus of a glucagon-like peptide-1 with the N-terminus of an IgG2 Fc section via a peptide linker, wherein the fusion protein comprises a sequence from amino acid position 20 to amino acid position 288 as shown in SEQ ID NO:

  • 4.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×